Related references
Note: Only part of the references are listed.Erythropoietic Protoporphyria: Phase 2 Clinical Trial Results Evaluating the Safety and Effectiveness of Dersimelagon (MT-7117), an Oral MC1R Agonist
Manisha Balwani et al.
BLOOD (2020)
Erythropoietic Protoporphyria and X-Linked Protoporphyria: pathophysiology, genetics, clinical manifestations, and management
Manisha Balwani
MOLECULAR GENETICS AND METABOLISM (2019)
Clinical Guide and Update on Porphyrias
Ulrich Stoelzel et al.
GASTROENTEROLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
Best practice guidelines on first-line laboratory testing for porphyria
Jacqueline Woolf et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2017)
Clinical, Biochemical and Molecular Characteristics of the Main Types of Porphyria
Urszula Szlendak et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2016)
Melanocortin 1 Receptor: Structure, Function, and Regulation
Erin M. Wolf Horrell et al.
FRONTIERS IN GENETICS (2016)
Share Paper
